Megan Paul, M.D.

Bio

Dr. Megan Rose Paul is a hematologist/oncologist at Rady Children's Hospital-San Diego. She primarily works with the Solid Tumor and Neuro-Oncology programs on both the inpatient unit and outpatient clinic, and does research in the area of pediatric brain tumors.

Dr. Paul earned a Bachelor of Science from the University of Arizona, graduating magna cum laude with honors. She received her medical degree and completed her pediatrics residency with the University of Arizona School of Medicine. Following her residency, Dr. Paul completed her fellowship in hematology/oncology at UC San Diego/ Rady Children"s Hospital and also completed an additional fellowship in pediatric neuro-oncology.

In addition to seeing patients, Dr. Paul does research at the University of California San Diego Moores Cancer Center where she is investigating the therapeutic vulnerabilities of medulloblastoma. Her research interests involve finding better treatment options for children with brain and spinal tumors as well as the supportive care of neurocognitive effects of pediatric brain tumor therapy. She is currently also a research fellow with the NIH T32 Pediatric Pharmacology program at UCSD.

When she is not at work, Dr. Paul enjoys spending time with her two children and dog.

Publications

Case 1: Progressive Hypotonia and Decreased Alertness in an 8-month-old Girl
Paul MR, Shehab K, Nguyen T

Treatment of immune thrombocytopenic purpura associated with cytomegalovirus infection in a child with pre-B cell acute lymphoblastic leukaemia after central nervous system relapse
Martinez AR, Paul MR, Kuo DJ

Deep Vein Thrombosis in a Young, Healthy Baseball Catcher: A Case Report and Review of the Literature
Abood KK, Paul MR, Kuo DJ

Challenges of assessing response to therapy in non-Hodgkin's lymphoma of the bone
Paul MR, Kuo DJ

Severe Neuropathic Pain With Concomitant Administration of Vincristine and Posaconazole
Lin MJ, Paul MR, Kuo DJ

Hematologic Manifestations of Nutritional Deficiencies: Early Recognition is Essential to Prevent Serious Complications
Yu JC, Shliakhtsitsava K, Wang YM, Paul MR, Farnaes L, Wong V, Kim J, Thornburg, CD

Treatment of Recurrent Refractory Pediatric Pre-B Acute Lymphoblastic Leukemia Using Inotuzumab Ozogamicin Monotherapy Resulting in CD22 Antigen Expression Loss as a Mechanism of Therapy Resistance
Paul MR, Wong V, Aristizabal P, Kuo DJ

The multikinase inhibitor RXDX-105 is effective against neuroblastoma in vitro and in vivo
Flynn SM, Lesperance J, Macias A, Phanhthilath N, Paul MR, Kim JW, Tamayo P, Zage PE

Clinical Impact of Next-generation Sequencing in Pediatric Neuro-Oncology Patients: A Single-institutional Experience
Barsan V, Paul MR, Gorsi H, Malicki D, Elster J, Kuo DJ, Crawford J

Trametinib-based Treatment of Pediatric CNS Tumors: A Single Institutional Experience
Paul MR, Pehlivan K, Milburn M, Yeh-Nayre L, Elster J, Crawford J

Characterization of G-CSF receptor expression in medulloblastoma
Paul MR, Huo Y, Liu A, Lesperance J, Garancher A, Wechsler-Reya R, Zage P